Brief: Tot Biopharm International Says Unit Entered Exclusive Promotion Service Agreement
21/12/2021 15:06
Dec 21 (Reuters) - TOT BIOPHARM International Co Ltd
1875.HK :
* UNIT ENTERED EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH
JIANGXI
JIXIN PHARMACEUTICAL
* AGREEMENT FOR MARKETING OF BEVACIZUMAB INJECTION IN
MAINLAND
CHINA
* UNIT WILL HAVE EXCLUSIVE PROMOTION RIGHT IN RESPECT OF
BEVACIZUMAB INJECTION
Further company coverage: 1875.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29